Reversion and conversion of Mycobacterium tuberculosis IFN-γ ELISpot results during anti-tuberculous treatment in HIV-infected children

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Connell, Tom G ^a,b,c,d   Davies, Mary Ann ^a   Johannisen, Christine ^a   Wood, Kathryn ^a   Pienaar, Sandy ^a   Wilkinson, Katalin A ^a,e   Wilkinson, Robert J ^a,e,f   Zar, Heather J ^a   Beatty, David ^a   Nicol, Mark P ^a,g   Curtis, Nigel ^a,b,c,d   Eley, Brian ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Infectious Diseases Unit   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; TUBERCULIN; TUBERCULOSTATIC AGENT; BACTERIAL ANTIGEN; DIAGNOSTIC AGENT;

ARTICLE; CHILD; CONTROLLED STUDY; DRUG RESPONSE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; TREATMENT DURATION; TUBERCULOSIS; ANIMAL; DRUG MONITORING; IMMUNOLOGY; INFANT; METHODOLOGY; SECRETION;

ANIMALS; ANTIGENS, BACTERIAL; CHILD, PRESCHOOL; DRUG MONITORING; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INTERFERON-GAMMA; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 77952710912     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-138     Document Type: Article

References (36)

1. Andersen P, Munk ME, Pollack JM, Doherty MT. Specific immune-based diagnosis of tuberculosis. The Lancet 2000, 356:1099-1104.
2. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007, 146:340-354.
3. Rangaka MX, Diwakar L, Seldon R, van Cutsem G, Meintjes GA, Morroni C, Mouton P, Shey MS, Maartens G, Wilkinson KA, et al. Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin Infect Dis 2007, 44(12):1639-1646. 10.1086/518234, 17516410.
4. Kampmann B, Whittaker E, Williams A, Walters S, Gordon A, Martinez-Alier N, Williams B, Crook AM, Hutton AM, Anderson ST. Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J 2009, 33(6):1374-1382. 10.1183/09031936.00153408, 19196815.
5. Nicol MP, Davies MA, Wood K, Hatherill M, Workman L, Hawkridge A, Eley B, Wilkinson KA, Wilkinson RJ, Hanekom WA, et al. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics 2009, 123(1):38-43. 10.1542/peds.2008-0611, 19117858.
6. Connell TG, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 2006, 61(7):616-620. 10.1136/thx.2005.048033, 2104654, 16601088.
7. Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children. PLoS ONE 2008, 3(7):e2624. 10.1371/journal.pone.0002624, 2440545, 18612425.
8. Haustein T, Ridout DA, Hartley JC, Thaker U, Shingadia D, Klein NJ, Novelli V, Dixon GL. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J 2009, 28(8):669-673. 10.1097/INF.0b013e3181a16394, 19633512.
9. Connell T, Tebruegge M, Ritz N, Curtis N. Interferon-gamma release assays for the diagnosis of tuberculosis. Pediatr Infect Dis J 2009, 28(8):758-759. 10.1097/INF.0b013e3181b00dbf, 19633530.
10. Powell DA. Interferon gamma release assays in the evaluation of children with possible Mycobacterium tuberculosis infection: a view to caution. Pediatr Infect Dis J 2009, 28(8):676-677. 10.1097/INF.0b013e3181ad5490, 19593249.
11. Connell TG, Tebruegge M, Ritz N, Bryant PA, Leslie D, Curtis N. Indeterminate interferon-gamma release assay results in children. Pediatr Infect Dis J 2010, 29(3):285-286. 10.1097/INF.0b013e3181c4822f, 20190616.
12. Davies MA, Connell T, Johannisen C, Wood K, Pienaar S, Wilkinson KA, Wilkinson RJ, Zar HJ, Eley B, Beatty D, et al. Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay. Aids 2009, 23(8):961-969. 10.1097/QAD.0b013e32832956ad, 19287300.
13. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004, 364(9452):2196-2203. 10.1016/S0140-6736(04)17592-2, 15610806.
14. Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, Pasvol G, Hill AV, Lalvani A. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001, 167(9):5217-5225.
15. Winslow GM, Roberts AD, Blackman MA, Woodland DL. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J Immunol 2003, 170(4):2046-2052.
16. Lalvani A. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment?. Clin Infect Dis 2004, 38(5):757-759. 10.1086/381763, 14986263.
17. Chee CB, KhinMar KW, Gan SH, Barkham TM, Pushparani M, Wang YT. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am J Respir Crit Care Med 2007, 175(3):282-287. 10.1164/rccm.200608-1109OC, 17082492.
18. Higuchi K, Harada N, Mori T. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis. Respirology 2008, 13(3):468-472. 10.1111/j.1440-1843.2008.01244.x, 18399875.
19. Wilkinson KA, Kon OM, Newton SM, Meintjes G, Davidson RN, Pasvol G, Wilkinson RJ. Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J Infect Dis 2006, 193(3):354-359. 10.1086/499311, 16388482.
20. Aiken AM, Hill PC, Fox A, McAdam KP, Jackson-Sillah D, Lugos MD, Donkor SA, Adegbola RA, Brookes RH. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 2006, 6:66. 10.1186/1471-2334-6-66, 1562425, 16573826.
21. Bosshard V, Roux-Lombard P, Perneger T, Metzger M, Vivien R, Rochat T, Janssens JP. Do results of the T-SPOT.TB interferon-gamma release assay change after treatment of tuberculosis?. Respiratory medicine 2009, 103(1):30-34. 10.1016/j.rmed.2008.09.012, 18977647.
22. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004, 38(5):754-756. 10.1086/381754, 14986262.
23. Dominguez J, De Souza-Galvao M, Ruiz-Manzano J, Latorre I, Prat C, Lacoma A, Mila C, Jimenez MA, Blanco S, Maldonado J, et al. T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment. Diagn Microbiol Infect Dis 2009, 63(1):43-51. 10.1016/j.diagmicrobio.2008.09.010, 19026511.
24. Ferrand RA, Bothamley GH, Whelan A, Dockrell HM. Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis 2005, 9(9):1034-1039.
25. Katiyar SK, Sampath A, Bihari S, Mamtani M, Kulkarni H. Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2008, 12(10):1146-1152.
26. Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Oka M. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. J Infect 2009, 58(3):197-204. 10.1016/j.jinf.2008.08.009, 18848730.
27. Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Okimoto N, Matsushima T, Kageoka T, Oka M. Clinical evaluation for diagnosing active TB disease and transitional change of two commercial blood tests. Scand J Infect Dis 2008, 40(8):629-634. 10.1080/00365540801932454, 18642159.
28. Pai M, Joshi R, Bandyopadhyay M, Narang P, Dogra S, Taksande B, Kalantri S. Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection 2007, 35(2):98-103. 10.1007/s15010-007-6114-z, 17401714.
29. Ulrichs T, Anding R, Kaufmann SH, Munk ME. Numbers of IFN-gamma-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int J Tuberc Lung Dis 2000, 4(12):1181-1183.
30. Wu-Hsieh BA, Chen CK, Chang JH, Lai SY, Wu CH, Cheng WC, Andersen P, Doherty TM. Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clin Infect Dis 2001, 33(8):1336-1340. 10.1086/323044, 11565073.
31. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2006, 174(7):831-839. 10.1164/rccm.200511-1783OC, 16799072.
32. Herrmann JL, Belloy M, Porcher R, Simonney N, Aboutaam R, Lebourgeois M, Gaudelus J, De Losangeles L, Chadelat K, Scheinmann P, et al. Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis. PLoS ONE 2009, 4(1):e4130. 10.1371/journal.pone.0004130, 2607538, 19125189.
33. Nicol MP, Pienaar D, Wood K, Eley B, Wilkinson RJ, Henderson H, Smith L, Samodien S, Beatty D. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis 2005, 40(9):1301-1308. 10.1086/429245, 15825033.
34. Hesseling AC, Cotton MF, Jennings T, Whitelaw A, Johnson LF, Eley B, Roux P, Godfrey-Faussett P, Schaaf HS. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009, 48(1):108-114. 10.1086/595012, 19049436.
35. Millington KA, Innes JA, Hackforth S, Hinks TS, Deeks JJ, Dosanjh DP, Guyot-Revol V, Gunatheesan R, Klenerman P, Lalvani A. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 2007, 178(8):5217-5226. 2743164, 17404305.
36. Mantegani P, Piana F, Codecasa L, Galli L, Scarpellini P, Lazzarin A, Cirillo D, Fortis C. Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection. Clin Med Res 2006, 4(4):266-272. 10.3121/cmr.4.4.266, 1764813, 17210976.